Beckon Medical-B (02170.HK) expects mid-term revenue of approximately 126 million to 131 million, a year-on-year increase of about 24.0% to 29.0%.

Zhitong Caijing APP news, Beikang Medical-B (02170.HK) announced that (i) revenue growth: for the six months ending June 30, 2026, it is expected to achieve revenue of approximately RMB 126 million to RMB 131 million, representing a year-on-year growth of approximately 24.0% to 29.0% compared to RMB 101 million for the six months ending June 30, 2025.